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Identification of an N-acetylglucosamine-6-0-sulfotransferase 
activity specific to lymphoid tissue: an enzyme with a possible 
role in lymphocyte homing 
Kendra G Bowman’, Stefan Hemmerich*, Sunil Bhakta*, Mark S Singer3, 
Annette Bistrup3, Steven D Rosen3 and Carolyn R Bertozzil 
Background: The leukocyte adhesion molecule L-selectin participates in the 
initial attachment of blood-borne lymphocytes to high endothelial venules (HEVs) 
during lymphocyte homing to secondary lymphoid organs, and contributes to 
leukocyte adhesion and extravasation in HEV-like vessels at sites of chronic 
inflammation. The L-selectin ligands on lymph node HEVs are mucin-like 
glycoproteins adorned with the unusual sulfated carbohydrate epitope, 6-sulfo 
sialyl Lewis x. Sulfation of this epitope on the N-acetylglucosamine (GIcNAc) 
residue confers high-avidity L-selectin binding, and is thought to be restricted in 
the vasculature to sites of sustained lymphocyte recruitment. The GlcNAc-6-0- 
sulfotransferase that installs the sulfate ester may be a key modulator of 
lymphocyte recruitment to secondary lymphoid organs and sites of chronic 
inflammation and is therefore a potential target for anti-inflammatory therapy. 
Results: A GlcNAc-6-0-sulfotransferase activity was identified within porcine 
lymph nodes and characterized using a rapid, sensitive, and quantitative assay. 
We synthesized two unnatural oligosaccharide substrates, GlcNAcPl +GGala-R 
and GalPl+4GlcNAcPi -+GGala-R, that incorporate structural motifs from the 
native L-selectin ligands into an unnatural C-glycosyl hydrocarbon scaffold. The 
sulfotransferase incorporated greater than tenfold more sulfate into the 
disaccharide than the trisaccharide, indicating a requirement for a terminal 
GlcNAc. Activity across tissues was highly restricted to the HEVs within 
peripheral lymph node. 
Conclusions: The restricted expression of the GlcNAc-6-0-sulfotransferase 
activity to lymph node HEVs strongly suggests a role in the biosynthesis of 
L-selectin ligands. In addition, similar sulfated epitopes are known to be expressed 
on HEV-like vessels of chronically inflamed tissues, indicating that this 
sulfotransferase may also contribute to inflammatory lymphocyte recruitment. We 
identified a concise disaccharide motif, GlcNAcPl-+6-Gala-R, that preserved 
both recognition and specificity determinants for the GlcNAc-6-0-sulfotransferase. 
The absence of activity on the trisaccharide GalPl+4-GlcNAcP1+6-Gala-R 
indicates a requirement for a substrate with a terminal GlcNAc residue, suggesting 
that sulfation precedes further biosynthetic assembly of L-selectin ligands. 
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Introduction 
Sulfated carbohydrates mediate a diverse range of highly 
specific recognition events in both pathogenic and normal 
processes [l]. For example, sulfation of the carbohydrates 
on pituitary hormones regulates serum half-life by creating 
a unique determinant that is selectively recognized by a 
sulfate-dependent hepatic receptor [Z-5]. Moreover, sulfa- 
tion patterns of heparan sulfate are highly heterogeneous, 
varying temporally and spatially during normal and patho- 
genic processes, and unique sulfated motifs are required 
for cytokine and growth factor binding and signaling [6-91. 
Accordingly, the sulfotransferases that install sulfate esters 
on oligosaccharide molecules are important targets for bio- 
logical and chemical investigations, and have become the 
focus of intense research during the past few years. 
Recently, a fundamental immunological process was dis- 
covered to be dependent upon carbohydrate sulfation [lo]. 
As part of their normal function, lymphocytes exit the 
bloodstream and migrate into secondary lymphoid tissue 
by first adhering to the endothelial cells lining the walls of 
specialized blood vessels [11,12]. This constitutive ‘lym- 
phocyte homing’ process is initiated in peripheral lymph 
nodes by the interaction between the leukocyte adhesion 
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molecule L-selectin and sulfated glycoprotein ligands on 
endothelial cells. In addition, L-selectin mediates a similar 
leukocyte-endothelial interaction in the vasculature at 
certain sites of inflammation [13-161. This initial adhesion 
event is a requisite first step in the cascade of events that 
leads to migration of the leukocytes into the tissue, a 
process termed extravasation. L-selectin is constitutively 
expressed on circulating lymphocytes, and in both homing 
and inflammatory recruitment, the attachment of lympho- 
cytes to the blood vessel wall is directed by the presentation 
of L-selectin ligands on cognate endothelial cells. 
In lymph nodes, lymphocyte extravasation is confined 
within specialized structures termed high endothelial 
venules (HEVs) [17]. Indeed, a defining feature of HEVs 
is their ability to initiate and sustain continuous lympho- 
cyte recruitment. HEVs are characteristic of all secondary 
lymphoid organs except spleen, and HEV-like vessels 
emerge in chronically inflamed tissues from a variety of 
human diseases. Interestingly, HEVs in normal lymph 
nodes and HEV-like vessels at sites of chronic inflamma- 
tion are known to incorporate a large amount of radiola- 
beled inorganic sulfate (35S0,2-), relative to typical vascular 
endothelium in a variety of species, including humans [ 171. 
The broad participation of L-selectin in numerous acute 
and chronic inflammatory disease states has directed sig- 
nificant attention to the molecular characterization of 
HEV-associated L-selectin ligands with the hope of iden- 
tifying possible avenues for therapeutic intervention [18]. 
Four discrete HEV-associated glycoproteins have been 
identified as L-selectin ligands in peripheral and mesen- 
teric lymph nodes. Now referred to as GlyCAM-1 [19,20], 
CD34 [21,22], MAdCAM- [23,241, and podocalyxin [ZSI, 
these glycoproteins all possess mucin-like domains char- 
acterized by dense clusters of O-linked glycans that 
determine L-selectin-binding activity. Furthermore, the 
oligosaccharides on all three glycoproteins are heavily sul- 
fated, and sulfation is essential for high-avidity L-selectin 
binding [26-B]. Similar sulfated ligands have been 
shown to be induced on HEV-like vessels within chroni- 
cally inflamed tissues, presumably in response to pro- 
inflammatory signals [29]. Sulfation of these mucins 
appears to correlate exclusively with their expression on 
HEVs at sites of leukocyte recruitment as nonsulfated 
GlyCAM-1 and CD34 glycoforms have been found in 
other, nonlymphoid tissues, and these glycoforms do not 
bind L-selectin [30,31]. 
An additional link between sulfation and lymphocyte 
recruitment comes from studies with MECA-79, an anti- 
body that stains lymph node HEVs and binds the 
L-selectin ligands in a carbohydrate- and sulfate-depen- 
dent manner [20,22,24,26]. MECA-79 staining is also 
observed on HEV-like vessels in a large number of chroni- 
cally inflamed tissue sites, including various cutaneous 
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Oligosaccharides bearing the 6-sulfo sialyl Lewis x motif (1) and the 
6’-sulfa sialyl Lewis x motif (2) are found on L-selectin ligands from 
murine lymph nodes. Evidence for the presence of structure 1 on 
human lymphoid tissue has also been reported. 
inflammatory lesions [32] and inflammatory bowel disease 
in humans [33], and pancreatic islets of Langerhans in 
nonobese diabetic (NOD) mice [34]. As L-selectin ligands 
induced in chronically inflamed tissues cross-react with 
MECA-79, they are likely to possess sulfated oligosaccha- 
rides similar to those on the L-selectin ligands expressed 
constitutively on lymph node HEVs. Furthermore, 
MECA-79 cross-reacts with the L-selectin ligands from 
murine, bovine, porcine and human tissues, indicating 
that the sulfated oligosaccharide structures, and hence the 
corresponding sulfotransferases, are also similar among 
several species [27,35]. 
Hemmerich et &. [36-381 analyzed the oligosaccharides on 
murine lymph node GlyCAM-1 in detail, leading to the dis- 
covery of the novel structures 1 and 2 depicted in Figure 1. 
Structure 1 contains the sulfated tetrasaccharide epitope 
6-sulfo sialyl Lewis x (Siaa2+3Galpl+4[Fuca1+3]- 
[S0,+6]GlcNAc) assembled on the core structure 
GlcNAc~l+6[Siaa2+3Gal~l-+3]GalNAcaSer/Thr. Struc- 
ture 2 contains a 6’-sulfo sialyl Lewis x tetrasaccharide 
(Siaa2-+3[SO,-+6]Gal~l-+4[Fucal-+3]GlcNAc) assem- 
bled on the same core epitope. In combination with the 
sulfate dependence of the L-selectin-GlyCAM-1 inter- 
action, the identification of these sialyl Lewis x sulfo- 
forms implicated GlcNAc-6-sulfate and/or Gal-6-sulfate 
as critical determinants for physiological L-selectin 
binding. The functional significance of HEV sulfate 
metabolism could be accounted for by these unusual sul- 
fated structures and their role in L-selectin binding. 
Accordingly, these observations suggest the presence of 
HEV-specific sulfotransferases that are constitutively 
expressed in lymph node HEVs and are induced in 
chronically inflamed tissues. 
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Figure 2 
Structure 1 and the two synthetic oligo- 
saccharide substrates 3 and 4. The blue and 
green boxes designate the core residues from 
which the disaccharide 3 and the trisaccharide 
4 were derived, respectively. Both substrates 
preserve the GlcNAc$l+6 linkage found in 
the native structure while incorporating a 
‘reducing’ end galactose residue in place of the 
GalNAc and a carbon-linked hydrocarbon tail. 
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The individual contribution of each sulfate ester to 
L-selectin-binding affinity has been examined using syn- 
thetic sulfated sialyl Lewis x analogs. In a series of studies, 
oligosaccharides related to sialyl Lewis x bearing GlcNAc-6- 
sulfate were found to bind to L-selectin with higher affinity 
than the unsulfated, parent oligosaccharide [39-41]. The 
contribution of Gal-6-sulfate to L-selectin binding is less 
clear: no measurable effect on L-selectin binding was 
observed in some studies [40,41], but in others Gal-6-sulfate 
was found to increase L-selectin-binding potency [42,43]. 
In choosing an initial sulfotransferase for biological inves- 
tigation, we focused our attention on a recent report by 
Kannagi and coworkers [44]. Using antibodies that selec- 
tively recognize a panel of sulfated sialyl Lewis x oligosac- 
charides, these researchers found evidence for the 
presence of GlcNAc-6-sulfated sialyl Lewis x on human 
peripheral lymph node HEVs and demonstrated that this 
modification was essential for L-selectin binding. By con- 
trast, no evidence for the Gal-6-sulfated epitope was 
obtained. Thus, it appears that sulfation of GlcNAc within 
sialyl Lewis x-like oligosaccharides is a feature shared by 
both human and murine L-selectin ligands. Collectively, 
these observations have directed our attention to the 
GlcNAc-6-0-sulfotransferase. 
The restricted vascular expression of the unusual sulfated 
motif h-sulfo sialyl Lewis x to sites of lymphocyte recruit- 
ment, coupled with the requirement for sulfate in 
L-selectin binding, present compelling evidence for the 
role of a GlcNAc-6-0-sulfotransferase as a key modulator 
of lymphocyte-endothelial cell adhesion and a possible 
target for anti-inflammatory therapy. We report here the 
characterization of a GlcNAc-6-0-sulfotransferase from 
porcine peripheral lymph node whose tissue distribution 
and substrate specificity suggest that it may be involved in 
the biosynthesis of L-selectin ligands. 
Results 
Development of an in vitro GIcNAc-6-0-sulfotransferase 
assay 
Two critical components of our biochemical study were 
the design and synthesis of a highly specific oligosaccha- 
ride substrate and the development of a sensitive and 
quantitative in vitro assay. The assay was based on the 
transfer of radiolabeled 35S-sulfate from 3’-phosphoadeno- 
sine-5’-phosphosulfate (PAPS), the activated sulfate donor 
for all known mammalian sulfotransferases [1,45-48], to 
the synthetic oligosaccharide substrate. An essential 
feature of the substrate was the presence of a hydrocarbon 
tail, which permitted selective adsorption onto reverse- 
phase silica gel after the enzymatic reaction and separation 
of the product from the other reaction components such as 
salts and unreacted “%-PAPS. Assays of this type are 
readily adaptable to several high-throughput architectures, 
including reverse-phase thin layer chromatography (TLC) 
plates and 96-well extraction plates, and have been useful 
in the characterization of other carbohydrate sulfotrans- 
ferases [3,49] and several glycosyltransferases [.50]. 
With the goal of identifying a minimal oligosaccharide 
substrate for the enzyme, we synthesized two compounds, 
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Synthesis of disaccharide substrate 3. 
disaccharide 3 (GlcNAc/31-+6Gala-R) and trisaccharide 4 
(Gal~l-+4GlcNAc~l+6Gala-R), that comprise structural 
motifs found in the native L-selectin ligands (structures 1 
and 2, Figure 2). Disaccharide 3 possesses the target 
GlcNAc residue linked to a galactose moiety that mimics 
the peptide-proximal GalNAc found in the native 
oligosaccharide. Trisaccharide 4 has an additional terminal 
galactose residue appended to the target GlcNAc. The 
synthetic substrates share the distinguishing feature of a 
reducing terminal carbon-linked glycoside (C-glycoside), 
which was designed to fulfill two purposes. The first is 
synthetic facility, as a-linked C-glycosides of galactose are 
readily prepared on a large scale with high stereo- 
selectivity [Sl] whereas a-linked 0-glycosides of GalNAc, 
the native linkage, are more arduous to prepare. Second, 
the C-glycosyl linkage is stable to chemical hydrolysis, 
which simplified the analysis of the sulfated substrate as 
described in detail below. 
The synthesis of compound 3 is outlined in Figure 3. In the 
retrosynthetic sense, we envisioned a key glycosyl coupling 
reaction between protected glucosamine analog 5 [52] and 
C-linked galactose derivative 6. Intermediate 6 was pre- 
pared from the previously reported C-ally1 galactoside 7 
[53]. Briefly, compound 7 was subjected to a hydrobora- 
tion reaction to afford alcohol 8, which was oxidized to the 
corresponding carboxylic acid and coupled with n-octy- 
lamine to afford compound 9 bearing the requisite hydro- 
carbon tail. Regioselective acetoxylation of the primary 
6-position using the procedure of Angibeaud and Utille 
[54], followed by saponification of the acetate ester, pro- 
vided compound 6 in which the 6-OH was exposed for 
glycosyl coupling. Reaction with compound 5, promoted 
by AgOTf, afforded disaccharide 10, which was converted 
to the target substrate 3 by a series of protecting group 
manipulations. Trisaccharide 4 was prepared in one step 
from disaccharide 3 by enzymatic galactosylation using 
UDP-galactose and a commercially available bovine milk 
galactosyltransferase (GalT) [55] (Figure 4). 
The sulfate donor used in the assay, 35S-labeled PAPS, is 
available from commercial suppliers. However, commercial 
PAPS has low specific activity and contains significant 
amounts of 3’,5’-phosphoadenosine, an inhibitor of sulfo- 
transferase activity. We therefore generated carrier-free 
35S-PAPS by in vitro enzymatic synthesis from carrier-free 
35S0,a- and adenosine triphosphate (ATP) according to the 
procedure of Long and coworkers [56]. 
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Enzymatic synthesis of trisaccharide 
substrate 4. 
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We chose porcine peripheral lymph nodes (PLNs) as a 
tissue source for the GlcNAc-6-0-sulfotransferase. 
Porcine tissues are readily available and porcine 
L-selectin ligands are structurally similar to those from 
murine, bovine and human lymph nodes, suggesting the 
expression of similar sulfotransferases across species 
[27,35]. We assumed the enzyme would be membrane 
associated and localized within Golgi compartments, 
similar to other carbohydrate sulfotransferases that have 
been previously cloned and characterized [5,49,57-631. 
We therefore prepared a microsomal extract by centrifu- 
gation of a postnuclear supernatant from homogenized 
PLNs. The resulting supernatant (cytosol) and pellet 
(microsomes) were tested in the sulfotransferase assay 
using substrate 3 as follows. Briefly, an aliquot of the 
crude enzyme preparation was incubated with 35S-PAPS 
(5 FCi) and oligosaccharide substrate 3, in the presence of 
a cocktail of protease and phosphatase inhibitors using 
conditions similar to those reported by Baenziger and 
coworkers [5]. The enzymatic reaction mixtures were 
incubated in a conical microtiter plate, and then loaded 
onto a 96-well reverse-phase Oasis extraction plate. The 
unreacted 35S-PAPS was washed from the cartridges with 
5% aqueous MeOH, and the 3sS-labeled product was 
then eluted with 70% MeOH. The 35S-labeled product 
could be quantified by one of two methods. In the first 
method, a small fraction of the eluate (5 pl) was trans- 
ferred onto a PVDF membrane and phosphorimaging 
analysis was performed. In the second method, radioac- 
tivity in the eluate could be quantified using a Hewlett- 
Packard TopCount microtiter plate scintillation counter. 
In accord with a membrane-bound protein integral to 
secretory compartments, the majority of the activity was 
found to be localized to the microsomes (data not shown). 
Substrate specificity of the GlcNAc-6-O-sulfotransferase 
We compared the relative activities of disaccharide 3 and 
trisaccharide 4 as substrates for the PLN-derived sulfotrans- 
ferase (Figures Sa,b). Radiolabeled sulfate was incorporated 
into compound 3 as a function of acceptor concentration, 
whereas only a modest amount of radioactivity was incor- 
porated into trisaccharide 4 under the same conditions, 
corresponding to less than 10% of the activity observed 
with the disaccharide (Figure Sb). Both substrates have 
several hydroxyl groups that could serve as sites for enzy- 
matic sulfation by irrelevant sulfotransferases. Thus, it was 
important to rigorously establish the position(s) of the 
sulfate ester on the radiolabeled products. Towards this 
end, we hydrolyzed 35S-sulfated disaccharide 3 by treat- 
ment with 100 mM HaSO, at 100°C for 10 min, conditions 
that cleave glycosidic linkages but leave sulfate esters 
largely intact (Figure SC) [36]. The C-glycosyl linkage was 
resistant to hydrolysis and, consequently, the hydrocarbon 
tail remained associated with the galactose residue while 
the GlcNAc residue was liberated. The hydrolysate was 
analysed by high-pH anion exchange chromatography 
(HPEAC) using a Dionex high performance liquid chro- 
matography (HPLC) system [64]. The C-glycosyl linkage 
on the galactose residue greatly simplified the analysis 
because the lack of a free reducing terminal hydroxyl 
group resulted in a retention time on a Dionex PA-l 
column distinct from any free sugars. Indeed, none of the 
radioactivity was found to be associated with the C-linked 
galactose residue, indicating exclusive sulfation on the 
GlcNAc residue. 
The regiochemistry of GlcNAc sulfation was determined 
by comparison of its retention time to those of authentic 
samples of GlcNAc-3-sulfate and GlcNAc-6-sulfate. The 
majority of the radioactivity from the hydrolysate co- 
eluted with GlcNAc-6-sulfate (Figure 5d), and a small 
amount of radioactivity co-eluted with an authentic 
sample of 35S0,2-, a n expected byproduct from the 
hydrolysis reaction. No evidence for sulfation elsewhere 
on GlcNAc was observed (for example, no radioactivity 
co-eluted with an authentic sample of GlcNAc-3- 
sulfate). Thus, sulfation of disaccharide 3 by the porcine 
PLN-derived microsomes occurred exclusively at the 
6-position of GlcNAc. Substrate 3 therefore presents a 
structural motif that is specifically recognized by a 
GlcNAc-6-0-sulfotransferase. No evidence for GlcNAc- 
6-sulfate was found on the product of sulfation of trisac- 
charide 4. The minute level of radioactivity associated 
with trisaccharide 4 was identified, after hydrolysis as 
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The sulfotransferase reaction with synthetic substrate 3 and analysis of 
the regiochemistry of the sulfated products. (a) Enzymatic transfer of 
Data points represent the average of five replicate experiments. The 
standard error of the mean for each point was between 3 and 10%. 
sulfate from radiolabeled 35S-PAPS to the disaccharide substrate 3. In (c) Hydrolysis of the products of enzymatic sulfation. In order to identify 
a typical reaction, 5 pCi ofradiolabeled PAPS and 500 uM substrate 3 the site of the sulfate ester, the glycosidic bond was selectively 
were incubated with Golgi microsomes from porcine peripheral lymph cleaved in aqueous H,SO,. (d) High pH anion-exchange 
nodes. The sulfated products were separated from the reaction mixture chromatography (HPAEC) was used to analyze radiolabeled products 
by solid phase extraction, facilitated by the hydrocarbon tail. of the hydrolysis. For the disaccharide 3, only GlcNAc-6-sulfate and 
(b) Substrate activity of disaccharide 3 and trisaccharide 4. Enzymatic free sulfate were detected (retention times of authentic standards are 
sulfation of compound 3 proceeded in a dose-dependent manner. In indicated with arrows). The same analysis of trisaccharide 4 revealed 
contrast, trisaccharide 4 was not sulfated at a significant level, only minute levels of free sulfate (data not shown) and no evidence for 
suggesting the enzyme activity requires a terminal GlcNAc residue. any other sulfated products. 
above, as free 35S-sulfate. Any possible sulfation on the 
monosaccharide residues was below the limits of detec- 
tion and therefore deemed insignificant. 
Quantitative parameters of the GlcNAc-6-0-sulfotransferase 
activity 
We next evaluated the dependence of enzyme activity on 
the concentrations of both compound 3 and PAPS to 
obtain more detailed quantitative parameters for the 
enzyme and preliminary mechanistic information. Analy- 
sis of double reciprocal plots (Figures 6a,b) revealed K, 
values of approximately 1 mM for disaccharide 3 and 
7 FM for PAPS, the latter value being comparable to the 
K, values for other carbohydrate sulfotransferases 
[63,65]. The observation of a common intersection point 
for the lines on both plots supports either a random or 
ordered mechanism and rules out a ping-pong mechanism 
involving a sulfoenzyme intermediate. Thus, it is likely 
that the sulfotransferase catalyzes the direct transfer of 
sulfate from PAPS to the oligosaccharide acceptor. This 
information will help guide the future design of sulfo- 
transferase inhibitors. 
Tissue and cellular distribution of the GlcNAc-6-O- 
sulfotransferase activity 
Finally, we prepared microsomal extracts from a panel of 
porcine tissues obtained from the same animal and 
screened for GlcNAc-6-0-sulfotransferase activity using 
disaccharide 3 as a substrate. Background incorporation of 
radiolabeled sulfate into endogenous substrates from the 
tissue preparation was determined in the absence of sub- 
strate 3 and subtracted from the radioactivity incorporated 
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disaccharide 3. (b) Plot of 1 /vO versus 1 /[PAPS] indicates a K, value 
for PAPS of 7 PM. 
in the presence of substrate 3. For comparative purposes, 
the extracts were normalized for total protein content. As 
shown in Figure 7a, the GlcNAc-6-0-sulfotransferase 
activity was highly localized to lymph nodes and spleen. 
By contrast, brain, heart, kidney, liver, lung, ovary, periph- 
eral blood leukocytes (PBLs) and skeletal muscle tissue 
showed low levels of activity. 
Lymph nodes comprise several cell types including lym- Many cell-surface glycoproteins bear 6-sulfated GlcNAc 
phocytes, stromal cells and the activated endothelial cells residues, such as the glycosaminoglycan chains of keratan 
that line the HEVs, referred to as high endothelial venule sulfate [66] and N-linked oligosaccharides on thyroglobu- 
cells or HECs. L-Selectin ligands have been shown by lin [67], HIV envelope components [68], and porcine 
histological methods to be localized to the HECs, and, zona pellucida [69]. GlcNAc-6-sulfate is presented 
accordingly, the GlcNAc-6-0-sulfotransferase responsible within a different oligosaccharide context for each of 
for their biosynthesis should be restricted to these cells. these, and several GlcNAc-6-0-sulfotransferases appear 
To investigate the cellular distribution of the lymph node to account for the biosynthesis within such a diverse 
enzyme, we fractionated porcine lymph nodes into lym- array of contexts. For example, a GlcNAc-6-O-sulfotrans- 
phocytes and stromal elements that include HECs, and ferase activity that sulfates the motif GlcNAcBl-+bMan, 
found the activity to reside predominantly in the crude 
stroma with only a minor amount in the lymphocyte popu- 
lation (Figure 7b). The stroma were then further fraction- 
ated into purified HECs and HEC-depleted stroma by 
immunomagnetic separation using MECA-79 as an HEC- 
specific marker. As shown in Figure 7b, the GlcNAc-6-0- 
sulfotransferase activity was highly concentrated in the 
HECs, paralleling the expression of MECA-79-reactive 
L-selectin ligands. 
Discussion 
Previous work has established that high-avidity L-selectin 
binding has a strict requirement for the sulfation of its 
cognate glycoprotein ligands, and that, in both murine and 
human lymph node endothelium, these ligands bear 
GlcNAc-6-sulfate within sialyl Lewis x oligosaccharides. 
We report here the characterization of a GlcNAc-6-0- 
sulfotransferase activity that is restricted to high endothe- 
lial cells within secondary lymphoid tissue, suggesting a 
possible role in the biosynthesis of L-selectin ligands. 
A substrate comparison revealed a greater than tenfold 
preference for disaccharide 3 over trisaccharide 4, indicat- 
ing that the GlcNAc-6-0-sulfotransferase requires a termi- 
nal GlcNAc residue and is impeded by the presence of a 
pl+4-linked Gal residue. This observation has implica- 
tions for the order of biosynthesis of L-selectin ligands as 
discussed below. We were concerned that irrelevant sulfo- 
transferases concurrently expressed in the Golgi compart- 
ment could recognize the synthetic substrates, thereby 
leading to competing activities. For example, the heparin 
sulfate GlcNAc-N-deacetylase/N-sulfotransferase [57], a 
Gal-3-0-sulfotransferase [6.5] and a GalNAc-l-O-sulfo- 
transferase [5] are established Golgi enzymes. To address 
this, we performed a regiochemical analysis of the sulfated 
products of disaccharide 3 and trisaccharide 4. For sub- 
strate 3, sulfation was confined exclusively to the h-posi- 
tion of GlcNAc, indicating that the synthetic disaccharide 
presents a motif that preserves both recognition and speci- 
ficity determinants for GlcNAc-6-0-sulfotransferase activ- 
ity, and is not recognized by other sulfotransferase 
activities present in the microsomal preparation. For 
trisaccharide 4, only a small amount of free sulfate was 
observed. The identity of any possible sulfate ester was 
obscured by the extremely low activity. 
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Tissue and cellular distribution of the GIcNAc-6-0-sulfotransferas e 
activity using disaccharide 3 as a substrate. (a) The enzyme activi tY 
was highly restricted to peripheral lymph nodes and spleen. 
Solubilized Golgi microsomes were prepared from each tissue and an 
equal amount of total protein was analyzed. The data represent the 
average from duplicate experiments and error bars represent the 
standard error of the mean. (b) The GlcNAc-6-0-sulfotransferase 
activity is restricted to lymph node HECs, with essentially no activity 
residing in the other cell populations. Whole-cell lysates with identical 
total protein content were analyzed and similar results were obtained 
in duplicate experiments. 
found within N-linked oligosaccharides, has been The biosynthetic pathway for L-selectin ligands has several 
recently characterized in rat liver [70]. Like the lymph potential points of interception, and, consequently, the 
node enzyme described here, the liver-derived enzyme sequence of biosynthetic assembly of structures 1 and 2 has 
requires a terminal GlcNAc residue and is blocked by a 
pl+4-linked Gal residue, raising the possibility that the 
same enzyme generates both products. We detected no 
significant GlcNAc-6-0-sulfotransferase activity in 
porcine liver using substrate 3, however. Thus, if a 
homologous enzyme exists in porcine liver, it does not 
recognize the GlcNAcpl+6Gal determinant and there- 
fore is distinct from the lymph node enzyme. Further- 
more, the tissue distribution of the rat activity on 
GlcNAcP1+6Man was markedly different from the 
activity with GlcNAcP1+6Gal that we observe in 
porcine tissues, and was found in a broad range of tissues 
[71]. By contrast, the activity described here is highly 
localized to lymph nodes and spleen. These observations 
indicate that the two GlcNAc-6-0-sulfotransferase activi- 
ties are distinct and that the substrate specificity of each 
enzyme is influenced by underlying carbohydrate struc- 
tures proximal to the terminal GlcNAc moiety. 
Keratan sulfate is widely distributed in connective tissue 
[72] and we were concerned that our assay would be per- 
missive for one or more keratan sulfate GlcNAc-6-O-sul- 
fotransferases. Trisaccharide 4, which possesses the 
Galpl+4GlcNAc motif found in keratan sulfate, was 
inactive as a substrate for the lymph node sulfotrans- 
ferase, however. Combined with the known activity of 
the keratan sulfate enzyme on GalPl+4GlcNAc 
oligomers [59], this result gives us confidence that our 
assay is specific for the enzyme of interest. 
The occurrence of GlcNAc-6-sulfate within the context of 
core 2 oligosaccharides (that is, those possessing the struc- 
tural motif [SO,+6]GlcNAc~l-+6[Gal~l+3]GalNAc) has 
been observed in only a few examples beyond the 
L-selectin ligands. Notably, oligosaccharides similar to 
structure 1 have been identified on respiratory mucins 
from patients suffering from cystic fibrosis [73]. A corre- 
sponding GlcNAc-6-0-sulfotransferase activity from 
human lung mucosa has been characterized recently and 
shown to modify only terminal GlcNAc residues, with 
the P-linked anomer being significantly more active than 
the a-linked anomer [63]. Although we found low activ- 
ity in porcine lung on disaccharide 3, we await the 
cloning of both sulfotransferases to determine if these 
are the same or two different enzymes. In addition, the 
[S03-+6]GlcNAc~1-+6[Gal~l-+3]GalNAc motif has also 
been observed in human colon carcinoma mucins from 
highly metastatic cells [74], indicating the presence of a 
related GlcNAc-6-0-sulfotransferase. The relationship 
between the lung, colon carcinoma and lymph node 
enzymes warrants further investigation and can be 
addressed using the assay developed in this study. 
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been a matter of significant interest [75-781. It has been 
established that the sialyl Lewis x epitope on the 
L-selectin ligands is produced by the successive action of 
an a2-+3sialyltransferase and an a1+3fucosyltransferase, 
most likely FucTVII, on a precursor bearing the 
Galfll--+4GlcNAc disaccharide [75]. In addition, Crommie 
and Rosen [75] have shown previously that sulfation of 
GlyCAM-1 in murine lymph nodes is blocked in the pres- 
ence of brefeldin A, which collapses the Golgi compart- 
ments and endoplasmic reticulum and separates them from 
the trans-Golgi network. This observation suggested that 
sulfation occurs in the trans-Golgi network and is a late step 
along the biosynthetic pathway. 
In contrast, the substrate specificity that we observed 
indicates that sulfation of GlcNAc must precede further 
elaboration of the P1+4Gal residue and, consequently, 
the other components of the sialyl Lewis x tetrasaccha- 
ride. Consistent with this proposal is the observation that 
several human fucosyltransferases recognize GlcNAc-6- 
sulfated 3’-sialyl-N-acetyllactosamine as a substrate 
[39,76,78]. Moreover, pl+4galactosyltransferases capable 
of modifying terminal GlcNAc-h-sulfate have been iden- 
tified [63,70]. It is possible that a complement of glyco- 
syltransferases successively installs the galactose, sialic 
acid and fucose residues within the trans-Golgi network, 
subsequent to GlcNAc sulfation. Alternatively, the 
GlcNAc-6-0-sulfotransferase might reside in an earlier 
secretory compartment and operate prior to delivery of 
the L-selectin ligands to the trans-Golgi network. In this 
scenario, the results obtained using brefeldin A might 
reflect a premature exposure of terminal GlcNAc 
residues to competing galactosyltransferases that prevent 
sulfation by blocking the GlcNAc epitope with a 
@1-+4Gal residue. Indeed, the expression level of struc- 
ture 1 under normal conditions might be regulated by the 
reciprocal activities of the GlcNAc-6-0-sulfotransferase 
and one or more galactosyltransferases. 
We observed a distribution of activity across tissue and cell 
type that is in accord with a possible role in L-selectin 
ligand biosynthesis. In a screen of ten porcine tissues, we 
found the GlcNAc-&O-sulfotransferase activity to be 
highly localized to PLNs and spleen. In contrast, activity in 
porcine brain, heart, kidney, liver, lung, ovary, peripheral 
blood leukocytes, and skeletal muscle was significantly 
lower. Furthermore, among the different cellular compo- 
nents of PLNs, HECs were the predominant source of the 
enzyme activity, whereas lymphocytes and HEC-depleted 
stromal cells- had essentially no activity. This distribution 
mirrors that of L-selectin ligand expression and MECA-79 
staining, which are confined to HECs within PLNs, and is 
consistent with a role for the GlcNAc-h-0-sulfotransferase 
in modulating L-selectin-mediated lymphocyte recruit- 
ment. Presently, the significance of the GlcNAc-6-O-sulfo- 
transferase activity in spleen is unclear. Although spleen 
participates in lymphocyte recirculation, the adhesion 
interactions that mediate this, and the role of L-selectin, 
are not well understood [79]. Perhaps this GlcNAc-6-0- 
sulfotransferase activity contributes to the synthesis of 
uncharacterized sulfomucins involved in homing to spleen. 
Finally, the similarity between sulfated L-selectin ligands 
in lymph node HEVs and those induced in HEV-like 
vessels in chronically inflamed tissues invites speculation 
regarding the possible role for the GlcNAc-6-O-sulfotrans- 
ferase in modulating inflammatory lymphocyte recruit- 
ment. Sulfated L-selectin ligands, reactive with MECA-79, 
are restricted to lymph node HEVs and HEV-like vessels 
in chronically inflamed organs. Inactive glycoforms of the 
L-selectin ligands have been observed outside HEV-like 
vessels and these glycoforms are invariably unsulfated 
[30,31]. Thus, a GlcNAc-6-0-sulfotransferase may be 
required to convert inactive glycoforms to functional 
L-selectin ligands. An intriguing hypothesis is that the 
GlcNAc-6-0-sulfotransferase is an induced modulator of 
sustained lymphocyte recruitment in chronically inflamed 
tissues, a possibility that we are currently exploring. 
Significance 
L-selectin participates in the initial attachment of blood- 
borne lymphocytes to high endothelial venules (HEVs) 
in peripheral lymph nodes and at sites of chronic inflam- 
mation. Previous work has established that L-selectin 
ligands in lymph node HEVs are sulfated glycoproteins, 
and that sulfation is critical for high-avidity L-selectin 
binding. N-Acetylglucosamine-6-sulfate (GlcNAc-6- 
sulfate) within the framework of the sialyl Lewis x 
tetrasaccharide is a component of L-selectin ligands in 
both murine and human peripheral lymph nodes and 
contributes to L-selectin binding affinity in vitro. The 
restricted presentation of sulfated L-selectin ligands at 
sites of sustained lymphocyte recruitment suggests the 
presence of an HEV-associated GlcNAc-6-O-sulfotrans- 
ferase. This enzyme might perform a critical function in 
normal lymphocyte homing and inflammatory lympho- 
cyte recruitment, and therefore represents a potential 
target for anti-inflammatory therapy. Here, we describe 
the first investigation of a GlcNAc-6-0-sulfotransferase 
activity that is restricted to endothelial cells within lymph 
node HEVs, sharing a similar tissue distribution with 
the sulfated L-selectin ligands. The design and synthesis 
of unnatural oligosaccharide substrates and the develop- 
ment of a sensitive and quantitative radiolabel transfer 
assay performed in a microtiter plate format were critical 
to this study. We identified a concise disaccharide motif, 
GlcNAcbl-+6GalaR, derived from native L-selectin 
ligands, that preserved both recognition and specificity 
determinants for the GlcNAc-6-0-sulfotransferase. The 
absence of activity on the related trisaccharide 
Gal~l-+4GlcNAc~l+6GalaR implicates a requirement 
for a substrate with a terminal GlcNAc residue, and 
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further suggests a biosynthetic pathway for L-selectin 3.91 (br app s, 1 H), 4.03 (m, 3 H), 4.50 (d, 1 H, J=i 1.9), 4.56 (d, 1 H, 
l igands in which sulfation precedes further elaboration of J=l 1.9) 4.59 (d, 1 H, J=11.2), 4.62 (d, 1 H, J=11.4), 4.69 (d, 1 H, 
the glycan. These.discoveries set the stage for the design 
J=l 1.8) 4.70 (d, 1 H, J=11.6), 4.75 (d, 1 H, J=11.9), 4.80 (d, 1 H, 
J=l 1.6), 7.34-7.37 (m, 20 H); 13C NMR: 6 21.98, 30.39, 67.70, 71.84, 
of inhibitors, for the detailed biological investigation of 72.87, 73.06, 73.18, 73.37, 74.25, 76.49, 127.38, 127.45, 127.48, 
this and related sulfotransferases, and for the study of 127.51, 127.63, 127.71, 127.81, 128.11, 128.16, 128.25, 128.31, 
L-selectin ligand biosynthesis. 130.01, 138.17, 138.12, 138.38, 138.45, 179.21; HRMS (FAB+) m/z: 
597.2852 (MH+ Cs7H4,07: requires 597.2852). 
Materials and methods 
Materials 
All chemical reagents were obtained from commercial suppliers and 
used without further purification. The ‘H and 13C NMR spectra were 
obtained using Bruker AMX-300, -400, or -500 spectrometers. Chemi- 
cal shifts are reported in 6 values relative to tetramethylsilane, and cou- 
pling constants (J) are reported in Hertz. Fast atom bombardment 
(FAB+) spectra and elemental analyses were obtained at the U.C. 
Berkeley Mass Spectral and Microanalytical Laboratory. 
Water used for biochemical procedures was doubly distilled and deion- 
ized using a Milli-Q system (Millipore). Protease inhibitors and Pefabloc 
SC were from Boehringer Mannheim or Sigma, ATP sulfurylase and 
inorganic pyrophosphatase were from Sigma, APS kinase was a gener- 
ous gift from Professor Sharon Long (Stanford University), porcine 
lymph nodes were supplied fresh from Pel-Freeze or harvested directly 
upon slaughter, 35Na,S04 was obtained from American Radiolabeled 
Chemicals, PEI cellulose plates were from VWR, and Oasis HLB Extrac- 
tion plates and Sep-Pak cartridges were obtained from Waters. 
3-(2,3,4,6-Tetra-0-benzyl-a-D-galactopyranosyl) propanol (8) 
Under an atmosphere of N2, 1.74 g (14.3 mmol) of 9-BBN dimer and 
1 g of 3 A molecular sieves were cooled to O”C, and a solution of 
6.50 g (11.5 mmol) of compound 7 in 12 ml of tetrahydrofuran (THF) 
was added via syringe. The solution was heated at reflux for 3 h. The 
solution was cooled to 0°C and an additional 1.74 g of 9-BBN were 
transferred to the flask followed by heating at reflux for an additional 
3 h. After cooling to O”C, the excess 9-BBN was quenched with 20 ml 
of EtOH, then 7 ml of 4 M  NaOH and 7 ml of H,O, were added. The 
reaction was warmed to room temperature (rt) and stirred for 8 h. The 
solution was diluted with 50 ml of ether, neutralized with of NH,CI, then 
successively washed with H,O and brine. The combined aqueous 
washes were extracted with ether and the combined organic layers 
dried over MgSO,. Following concentration, the product was purified 
by silica gel chromatography eluting with 6:l hexanes/ethyl acetate to 
give 6.93 g (I 00%) of a clear, colorless syrup; IR (thin film) 3444, 
3087, 3062, 3029, 2915, 2869, 1496, 1454, 1369, 1208, 1028 
cm-‘; ‘H NMR (400 MHz, CDCI,): 6 1.63-1.95 (m, 4H), 3.18 (br s, 1 
H), 3.55-3.67 (m, 3 H), 3.71 (dd, 1 H, f=2.8, 7.3), 3.75-3.84 (m, 2 H), 
3.94-4.01 (m, 3 H), 4.46 (d, 1 H, J=12.0), 4.52 (d, 1 H, J=10.3), 4.54 
(d, 1 H, J=11.9), 4.56 (d, 1 H, J=11.8), 4.64 (app d, 2 H, J=11.3), 
4.67 (d, 1 H, J=12.2), 4.74 (d, 1 H, J=l3.1), 7.27-7.35 (m, 20 H); 13C 
NMR: 6 22.1, 22.1, 23.7, 24.1, 26.3, 28.3, 28.3, 29.7, 30.2, 31.0, 
31.1, 31.4, 32.0, 34.1, 34.2, 36.1, 43.0, 43.3, 44.8, 62.4, 71.8, 73.1, 
73.2, 73.3, 74.5, 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.3, 
128.4, 138.2, 138.3, 138.5, 138.6; MSE(FAB+) m/z 583 (M+H). Anal. 
calc’d. for C,,H,,O,: C, 76.26; H, 7.26. Found: C, 76.10; H, 7.40. 
3-(2,3,4,6-Tetra-0-benzyi-a-D-galactopyranosyi) propanoic 
acid (8a) 
A solution of 6.90 g (1 1.8 mmol) of 8 in 50 ml of acetone was cooled to 
0%. Over a period of 12 min, 12 ml (24 mmol) of Jones’ reagent was 
added dropwise, after which the reaction flask was warmed to rt for 3 h. 
Excess Jones’ reagent was quenched with 10 ml of isopropanol, and the 
solution was diluted with 100 ml of ether, washed successively with 
NaHCO,, H,O, and brine, then dried over Na,SO,. Purification of the 
concentrated product was achieved by silica gel chromatography 
eluting with 5:l hexanesiethyl acetate to afford 6.13 g (89%) of a clear, 
colorless syrup; IR (thin film): 3088, 3064, 3031, 2967, 2248, 1710, 
1145 cm-‘; 1 H NMR (500 MHz, CDCr3): F 1.95 (m, 1 H), 2.03 (m, ; r-i), 
2.41 (m, 1 H), 2.53 (m, 1 H), 3.68 (dd, 1 H, J=4.8, 10.5), 3.78 (m, 2 H), 
N-Octyl-3-(2,3,4,6-tetra-O-benzyl-a-o-galactopyranosyl) 
propionamide (9) 
A solution of 1.49 g (2.50 mmol) of 8a, 826 ml (3.75 mmol) of n-octy 
lamine, 507 mg (3.75 mmol) of hydroxybenzotriazole, and 719 mg 
(3.75 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) in 
25 ml of 3:l CH,CN/CH,Cls was stirred under an atmosphere of N, at 
rt. After 12 h, the solution was diluted with 50 ml of CHCI, and 50 ml of 
NH&I. The organic layer was collected and washed with H,O and 
brine, then dried over MgSO,. Purification was achieved by silica gel 
chromatography eluting with 5:l hexaneslethyl acetate to yield 1.62 g 
(92%) of a clear, pale yellow syrup; IR (thin film): 3290, 3064, 1653, 
1540 cm-‘; ‘H NMR (400 MHz, CDCI,): 6 0.87 (t, 3 H, J=6.7), 1.22. 
1.34 (m, 12 H), 1.84 (m, 1 H), 1.94 (m, 1 H), 2.20-2.23 (m, 2 H), 3.05 
(m, 1 H), 3.12 (m, 1 H), 3.53 (dd, 1 H, J=3.3, 10.7), 3.68-3.74 (m, 2 H), 
3.95-4.04 (m, 4 H), 4.48-4.67 (m, 8 H), 5.94 (br s, 1 H), 7.25-7.35 (m, 
20 H); i3C NMR: 6 14.2, 22.7, 27.0, 29.3, 29.3, 31.9, 33.0, 39.6, 67.6, 
69.4, 73.0, 73.1, 74.3, 76.1, 76.9, 127.6, 127.7, 127.8, 127.8, 128.0, 
128.1, 128.4, 128.4, 128.5, 128.5, 138.2, 138.3, 138.4, 138.5, 172.9. 
HRMS (FAB+) m/z 707.4186 (MH+ C,,H,,O,N requires 707.4186). 
N-Octyl-3-(2,3,4-tri-O-benzyl-cx-~-galactopyranosyl) 
propionamide (6) 
A solution of 800 mg (1 .lO mmol) of 9 in 4 ml of CH,CI, and 4 ml of 
acetic anhydride was cooled to -42°C. Over the course of an hour, a 
solution of 220 ~1 of trimethylsilyl trifluromethanesulfonate (TMSOTf) in 
375 ~1 CH,CI, was added dropwise via syringe and the solution was 
stirred for an additional 3 h. The solution was diluted with 10 ml of 
CHCI,, and then quenched with NaHCO,. The organic phase was 
washed successively with H,O and brine, and then dried over MgSO,. 
Concentration in vacua afforded a clear, colorless syrup which was 
carried on to the next reaction without further purification. To obtain full 
characterization, an analytical sample was purified by silica gel chro- 
matography eluting with 1O:l hexanes/ethyl acetate. IR (thin film): 
3386, 1737, 1648, 1541, 1454, 1370, 1239, 1098 cm-‘; ‘H NMR 
(500 MHz, CDCI,): F 0.88 (t, 3 H, J=1.4), 1.27 (m, 10 H), 1.47 (m, 1 
H), 1.98 (m, lH), 2.06 (s, 3 H), 2.15 (m, 1 H), 2.21 (m, 1 H), 3.20 (m, 2 
H), 3.54 (app s, 1 H), 3.74 (app s, 1 H), 3.97 (m, 2 H), 4.09 (m, 1 H), 
4.22 (app d, 1 H, J=12.2), 4.60 (m, 6 H), 4.79 (m, 1 H), 6.03 (s, 1 H), 
7.26-7.44 (m, 15 H); r3C NMR : 6 13.58, 20.87, 22.41, 25.49, 26.74, 
29.00, 29.03, 29.40, 31.57, 32.87, 39.33, 61.10, 71.98, 72.64, 
72.91, 72.97, 73.31, 76.57, 127.36, 127.41, 127.48, 127.58, 127,70, 
127.85, 128.05, 128.19, 128.20, 128.22, 137.70, 137.86, 138.05. 
MS (FAB+): m/z 660 (MH+). Anal Calcd. for C,,H,,O,N: C, 72.81; H, 
8.10; N, 2.12. Found: C, 73.03; H, 8.01; N, 1.97. The product of the 
previous reaction was dissolved in 10 ml of a 10 mM solution of 
NaOCH, in methanol and stirred overnight. The reaction was neutral- 
ized by H+ ion exchange resin, and the product was concentrated and 
purified by silica gel chromatography eluting with 2:l hexaneslethyl 
acetate to give 564 mg (92% from 9) of a clear, colorless syrup; IR 
(thin film): 3306, 3088, 3064, 3030, 2953, 1641, 1549, 1454, 1092 
cm-l; ‘H NMR (500 MHz, CDCI,): 6 0.92 (t, 3 H, b6.8), 1.28 (m, 10 
H), 1.48 (m, 2 H), 1.81 (m, 1 H), 2.04 (m, 1 H), 2.25 (d app t, 1 H, 
J=6.1, 13.9), 2.37 (m, 1 H), 3.18 (br s, 1 H), 3.19 (m, 2 H), 3.62 (m, 1 
H), 3.68 (m, 1 H), 3.76 (m, 1 H), 3.97 (m, 2 H), 4.04 (d app t, 1 H, 
J=2.8, 10.9), 4.14 (m, 1 H), 4.48 (d, 1 H, J=12.1), 4.65 (d, 1 H, 
J=11.9), 4.68 (d, 1 H, J=12.0), 5.89 (brm, 1 H), 7.19-7.35 (m, 15 H); 
‘3C NMR: S 14.01, 22.55, 26.88, 29.13, 29.18, 29.49, 31.71, 33.16, 
59.93, 68.73, 72.46, 72.99, 73.16, 74.21, 74.30, 75.28, 127.57, 
127.60, 127.72, 127.80, 128.00, 128.34, 137.99, 138.13, 138.30, 
173.08. HRMS (FAB+) m/z: 618.3795 (MH+ for C,,H,,O,N requires 
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618.3795). Anal. calc’d for C,sH,,O,N: C, 73.87; H, 8.32; N, 2.27. 
Found: C, 73.65; H, 8.39; N, 2.04. 
Protected disaccharide 70 
Under an atmosphere of N, protected from light, 336 mg (1.30 mmol) 
of silver trifluoromethanesulfonate (AgOTf), 1 ml of CHsNO,, and 
200 mg of 4 A molecular sieve dust were transferred into a flame-dried 
flask and stirred for 1 h. After the flask was cooled to -2O”C, a solution 
of 537 mg (0.870 mmol) of compound 6, 651 mg (1.31 mmol) of com- 
pound 5 [52] and 105 mg (0.870 mmol) of sym-collidine in 1 ml of 
CHsNO, was precooled to -2O’C and added via syringe. The reaction 
was warmed to room temperature and stirred for 48 h, then neutralized 
with 1 mL saturated NaHCO,, diluted with CHCI,, and filtered through 
Celite. The filtrate was successively washed with ice cold 1 M  HCI and 
brine, dried over Na,SO,, concentrated and purified by silica gel chro- 
matography eluting with 3:2 hexanesiethyl acetate to afford 612 mg 
(68%) of a clear, colorless syrup. ‘H NMR (400 MHz, CDCI,): F 1.27 
(m, 3 H), 1.60 (m, 10 H), 1.88 (s, 3 H). 2.05 (s, 3 H), 2.13 (s, 3 H), 
3.96 (m, 2 H), 4.12-4.33 (br m, 8 H), 4.38 (dd, b4.1, 12.4, 1 H), 4.67 
(dd, b3.4, 11.3, 1 H), 5.19 (app t, 1 H), 5.87 (dd, J=9.2, 10.7, 1 H), 
6.16 (dd, J=9.1, 11.3, 1 H), 7.32 (m, 15 H), 7.74-7.91 (br m, 4 H). 
Disaccharide 3 
Compound 10 was dissolved in a slurry of 100 mg of Pd(OH), on 
carbon, activated by removal of water in WCUO, and 3 ml methanol. The 
reaction mixture was stirred under an atmosphere of H, at r-t for 3 h, 
then filtered through Celite and concentrated to give 451 mg (1000/o) of 
a clear, colorless syrup. This intermediate was dissolved in 5 ml of 
butanol and 3.6 g (59 mmol) ethylenediamine were added. The solution 
was heated to 85’C for 30 h under an atmosphere of N,. The reaction 
was diluted with toluene and concentrated in vacua to give a brown 
syrup that was carried on to subsequent reactions without further purifi- 
cation or characterization. This product was dissolved in a solution of 
5 ml 1:2 acetic anhydridelpyridine and 25 mg dimethylaminopyridine 
(DMAP) and stirred overnight at rt. The reaction was diluted with meth- 
ylene chloride and washed successively with ice cold 1 N HCI, 1 M  
CuSO,, saturated NaHCO,, and brine, then dried over Na,SO,. Purifi- 
cation was achieved by silica gel chromatography eluting with a gradi- 
ent of 1:2 hexanes/ethyl acetate to 100% ethyl acetate to afford 
237 mg (50% over two steps) of a clear, colorless syrup; ‘H NMR 
(500 MHz, CDCI,): 6 0.86 (app t, J=8.8, 3 H), 1.27 (m, 14 H), 1.51 (m, 
2 H), 1.4 (s, 3 H), 1.96 (s, 3 H), 2.02 (s, 3 H), 2.04 (s, 3 H), 2.05 (s, 
3H), 2.08 (s, 3 H), 2.1 1 (s, 3 H), 3.21 (m, 2 H), 3.39 (app t, J=9.8, 1 
H), 3.63 (m, 1 H), 3.86 (app d, J=lO.l, 1 H), 3.92 (d, J=8.1, 1 H), 4.11 
(m, 3 H), 4.28 (dd, b4.5, 12.4, 1 H), 4.35 (d, J=8.3, 1 H), 5.04 (app t, 
J=9.3, 1 H), 5.10 (t, h9.4, 1 H), 5.14 (dd, J=3.4, 10.6, 1 H), 5.32 (m, 
2 H), 5.60 (d, bl2.0, 1 H), 7.47 (app t, 1 H); 13C NMR: 6 14.09, 
20.58, 20.62, 20.65, 20.68, 20.70, 20.86, 22.63, 23.36, 27.10, 29.25, 
29.30,29.58,30.72,31.83,39.57,41.16,53.90,61.75,67.79,68.11, 
68.14, 68.57, 69.14, 71.90, 72.29, 72.97, 80.44, 101.45, 169.20, 
169.89, 170.13, 170.18, 170.63, 170.67, 171.29, 171.88. 
The preceding compound (75 mg, 0.14 mmol) was dissolved in 5 ml 
of 10 mM NaOMe in methanol, and stirred overnight at rt. The reac- 
tion was neutralized by H+ cation exchange resin and then concen- 
tration to afford 52 mg (100%) of disaccharide 3 as an amorphous 
solid; ‘H NMR (500 MHz, D,O): 6 0.86 (app t, 3H), 1.27 (m, 12 H), 
1.50 (br s, 2 H), 1.93 (m, 3 H), 2.02 (s, 3 H), 2.08 (m, 1 H), 2.18 (m, 
1 H), 2.3 (m, 1 H), 3.16 (m, 2 H), 3.44 (m, 2 H), 3.54 (app t, 1 H), 
3.66 (app t, 1 H), 3.72 (m, 4 H), 3.77 (app t, 1 H), 3.91 (m, 2 H), 
3.97 (m, 4 H), 4.51 (d, 1 H, J=8.4); 13C NMR (CD,OD): F 14.37, 
23.08, 23.66, 28.04, 30.33, 30.38, 30.39, 32.95, 33.36, 40.44, 
49.56, 49.59, 57.11, 62.75, 69.88, 69.96, 70.40, 71.73, 72.10, 
76.11, 77.90, 79.37, 103.05, 175.82, 173.71. HRMS (FAB+) m/z: 
551.3180 (MH+ for C,,H,,O,,N, requires 551.3180). 
Trisaccharide 3 
The galactosyltransferase reaction was performed essentially as 
described by Oehrlein et a/. [55]. Disaccharide 3 (18.5 mg, 33.6 umol), 
UDP-galactose (25 mg, 41 .O pmol), galactosyltransferase (2.72 U), and 
calf intestinal alkaline phosphatase (16.3 U) were incubated in 50 mM 
cacodylate (pH 7.4), 1% BSA, and 30 mM MnCI, in a final volume of 
840 ul at 37’C for 2 h. The product was isolated by loading the reaction 
onto a Cl 8 cartridge, washing with 10 ml of H,O, and finally eluting 
with 5 ml of 70% aqueous methanol. Concentration followed by 
lyophilization gave 23.9 mg (100%) of a white, amorphous solid; 1H 
NMR (500 MHz, CDsOD): 6 0.84 (app t, J=6.5, 3H), 1.24 (m, 10 H), 
1.44 (m, 2 H), 1.86 (m, 2 H), 1.91 (s, 3 H), 2.10 (m, 1 H), 2.27 (m, 1 H), 
3.10 (m, 2 H), 3.36 (m, 1 H), 3.41 (dd, J=3.50, 10.0, 1 H), 3.74 (dd, 
k7.5, 9.5, 1 H), 3.50-3.63 (m, 6 H), 3.69 (dd, J=7.5, 10.0, 1 H), 3.74. 
3.83 (m, 7 H), 3.60 (dd, J=2.5, 9.0, 1 H), 3.90 (dd, J=4.0, 10.5, 1 H), 
4.32 (dd, J=8.8, 18.0, 1 H). 13C NMR (CD30D): F 13.84, 15.37, 
23.12, 24.06, 24.66, 27.51, 29.04, 29.80, 29.86, 31.33, 31.37, 31.39, 
31.70, 33.95,41.44, 50.54, 63.45, 70.98, 71.25, 73.53, 75.24, 75.77, 
77.49, 78.10, 81.84, 104.02, 106.04, 158.22, 176.82. HRMS (FAB+) 
m/z: 713.3708 (MH+ for C3,Ha70,eN2 requires 713.3708). 
Isolation of microsomes from fresh porcine tissues 
The following buffer and protease inhibitor cocktails (PIG) were used in 
the isolation procedures, STKM buffer: 250 mM sucrose, 50 mM Tris- 
Cl pH 7.5, 25 mM KCI, 5 mM MgCI,, and 1 ~llml of protease inhibitor 
cocktails PIC-I and PIC-II. PIC-I: To 2.5 ml of aprotinin solution (5-l 0 
trypsin inhibitory units/ml) were added 3.0 mg of Leupeptin, 12.5 mg of 
Pefabloc SC, 5 mg of Antipain, 5 mg of Turkey trypsin inhibitor, and 
2.5 mg of benzamidine. PIG-II: Chymostatin (10 mg) and Pepstatin 
(5 mg) were dissolved in 5 ml of DMSO. All buffers were supplemented 
with 1 u.llml of each PIC, and all manipulations were carried out at 4°C. 
Tissues for the comparative tissue scan were harvested from the same 
eight month old female Yucatan micropig euthanized by intravenous 
administration of ketamine HCI. Following dissection, tissues were snap 
frozen in liquid nitrogen. Additional porcine lymph nodes for enzyme 
characterization were purchased frozen from Pel-Freeze (Rogers, AZ). 
Frozen tissues were placed in a motor-driven tissue grinder and 
crushed to powder in liquid nitrogen. The powdered tissues were sus 
pended in a tenfold volume of SKTM buffer. Tissue suspensions were 
then homogenized in a 10 ml glass homogenizer with a drill-driven 
conico-cylindrical teflon pestle (five passes at 800 rpm). The 
homogenates were centrifuged at 680 x g for 10 min, the supernatant 
was collected, and the nuclear/mitochondriaI pellet was discarded. The 
supernatant was then centrifuged at 10,000 x g for 10 min, the new 
supernatant collected and the lysosomal pellet was discarded. The 
supernatant was then centrifuged at 100,000 x g for 1 h, and the micro- 
somal pellet was collected and used as as a source of enzyme after 
processing as described below. The supernatant from this final centrifu- 
gation step (cytosol) was collected and analyzed as well. 
The microsomal pellet was washed by resuspension in five volumes of 
150 mM Tris-Cl pH 8.0 supplemented with 1 x PIC-I and PIC-II fol- 
lowed by centrifugation at 100,000 x g for 1 h. The pellet was solubi- 
lized in lysis buffer (50 mM HEPES pH 7.5, 2.5% Triton X-100 
supplemented with 1 x PIC-I and PIC-2) using a hand-held microfuge 
tube homogenizer. Lysates were cleared by recentrifugation for 1 h at 
100,000 x g, and then 114 volume of 50% glycerol was added to each 
cleared lysate. The total protein concentrations in the lysates and 
cytosolic supernatants were determined using the Pierce BCA protein 
assay. Thereafter, each lysate was diluted with lysis buffer to a concen- 
tration of 2 mglml total protein, and typically 10 ~1 of the lysate was 
used in a sulfotransferase assay. 
Cellular fractionation of porcine lymph nodes 
Porcine lymph nodes were fractionated into lymphocytes, high 
endothelial cells (HEC) and HEC-depleted stromal cells essentially as 
described by Girard and Springer [80]. Briefly, 4.2 g of fresh procine 
peripheral lymph nodes were diced and teased on a stainless steel 
screen (86 FM pore size, Tylinter) and lymphocytes were washed 
through the screen by flushing with RPMI. These cells comprised the 
lymphocytes analyzed for sulfotransferase activity. The remaining 
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stromal elements were digested with collagenase I and DNAse I in 
RPMI for 15 min to degrade extracellular matrix components, and the 
digested stroma were re-filtered on the screen to remove additional 
lymphocytes. After an 1 h digestion with collagenase I and DNAse I, 
the liberated stromal cells were flushed through the screen with buffer 
(PBS, 1% BSA, 5 mM EDTA). These cells comprised the stromal cells 
analyzed for sulfotransferase activity. HEC cells were purified from the 
stromal cells by immunomagnetic separation using the MAb MECA-79 
as an HEC-specific marker. The stromal cells were incubated with 
MECA-79 for 15 min at 4”C, washed by centrifugation and resus- 
pended in buffer. The cells were then incubated with a biotinylated sec- 
ondary antibody (anti-Rat IgM) for 15 min at 4”C, washed and 
resuspended. The labeled cells were incubated with streptavidin-mag- 
netic beads (Miltenyi Biotech, MACS system) for 15 min, and applied 
to a WHM separation column in a magnetic field. HEC-depleted 
stromal cells were washed through the column with buffer, and mag- 
netic HEC were subsequently obtained by removina the column from 
the field and washing with buffer. The separated ccl! populations were 
solubilized with lysis buffer for enzyme assays. 
Expression and purification of APS kinase 
A plasmid containing the APS kinase gene from R. meliloti fused to an 
N-terminal (His), sequence was a generous gift from Professor Sharon 
Long (Stanford University). APS kinase-(His), was overexpressed in 
E. co/i Ml5 cells containing the plasmid pLys using standard proto- 
cols. The cells were lysed by three quick freeze-thaw cycles, and the 
enzyme was purified from the lysate by nickel affinity chromatography 
using Ni-NTA Agarose (Qiagen) eluting with a gradient of imidazole in 
5 mM j3-mercaptoethanol according to the manufacturer’s instructions. 
Enzymatic synthesis of W-PAPS 
Carrier-free 35SPAPS was synthesized in vitro using a procedure 
similar to that described by Long and coworkers 1561. Briefly, 1 mCi of 
carrier-free 35S-Na,S0, and 30 mM ATP were incubated with approxi- 
mately 45 ug of APS kinase, 0.12 U ATP sulfurylase (Sigma), and 8.3 
U inorganic pyrophosphatase (Sigma) in 60 1.11 Buffer A (20 mM Tris- 
HCI (pH 8.0) 30 mM KCI, 40 mM MgCI,, 1 mM EDTA, 1 mM DTT, 
10% glycerol) for 12 h at 30°C. Quantification of conversion was 
accomplished through separation of reaction components by TLC on 
polyethyleneimine (PEl)-cellulose eluting with 0.9 M  LiCI, followed by 
phosphorimaging analysis (Model 445 SI, Molecular Dynamics). Incor- 
poration of 35S-S0,2- into 35S-PAPS typically exceeded 98%. 
Assay for sulfotransferase activity 
Standard assay reactions of 25 pl were carried out in 96-well plates at 
pH 6.5 in Buffer ST (15 mM MOPSO, 1% Triton-X 100, 40 mM p-mer- 
captoethanol, 6 mM Mg(OAc)2, 10 mM NaF, 1 mM ATP, 13.3% glyc- 
erol). We determined the optimal pH as 6.5 from an activity profile over 
a pH range of 5.0-8.0. The reactions were performed with 500 pM dis- 
accharide 3, 5 FCi 35S-PAPS, 3 uM PAPS, and microsomal extract 
containing 15-20 pg total protein, in the presence of the aforemen- 
tioned protease inhibitors. Reactions were incubated for 2 h at 37iC, 
then terminated by dilution to 1 ml followed by loading onto Oasis 96- 
well reverse-phase extraction plates (Waters) at a flow rate of 1 mllmin. 
Each column in the plate was washed with 8 ml of 5% methanol. 
Elution and quantification of the sulfated product was achieved by one 
of two methods: In Method A, the sulfated product was eluted with 
150 @I of 100% methanol followed by quantification with a Hewlett 
Packard TopCount scintillation counter. In Method B, the the sulfated 
product was eluted with 1 ml of 700/, methanol, and 5 PI of eluant from 
each reaction was spotted onto a PVDF membrane and quantified of 
using a phosphorimager. 
Regiochemical analysis of the products of enzymatic sulfation 
The regiochemistry of substrate sulfation was determined using a pro- 
cedure adapted from that described by Hemmerich et al. [36]. Briefly, 
the eluant of the sulfotransferase reaction was lyophilized then sub- 
jected to acid hydrolysis by treatment with 100 mM H,SO,, overlaid 
with mineral oil, for 10 min at 100°C. The hydrolysate was neutralized 
with 1 equivalent of 1 M  NH,OH, and then analyzed by high-pH anion 
exchange chromatography (HPAEC, Dionex) on a CarboPac PA-1 
column with pulsed amperometric detection. Elutions were performed 
at 1 ml/min using the following gradient: 50 mM NaOAc in 150 mM 
NaOH for 5 min, followed by a linear gradient of 50-850 mM NaOAc 
in 150 mM NaOH over 30 min. Standards for GlcNAc-3sulfate, 
GlcNAc-6-sulfate, Gal-4-sulfate, and Gal-6-sulfate (Sigma) were used 
at 1 mM; Gal-3-sulfate was obtained by acid hydrolysis of sulfatides 
(Sigma) under the conditions above, and purified by removing lipid 
byproducts on a C,, Sep-Pak cartridge followed by lyophilization. 
Radiolabeled products were detected by collecting 0.5 ml fractions 
followed by scintillation counting. 
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